ADESPI: Adherence to Spiriva in Patients With COPD, Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice in Central & Eastern European Region
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2014
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms ADESPI
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 20 Jan 2014 According to ClinicalTrials.gov record study status changed from active, no longer recruiting to completed.
- 12 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Oct 2012 Planned End Date changed from 1 Aug 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov record.